Adeno-associated Virus | CHOP Research Institute
 

Adeno-associated Virus

Cornerstone Blog

Clinical Vector Core Supports Life-Changing Gene Therapy After AADC Diagnosis

Published on
Jun 21, 2024
Clinical Vector Core Supports Life-Changing Gene Therapy
The Clinical Vector Core created a viral vector that changed the life of a child diagnosed with AADC deficiency.
Cornerstone Blog

Building on Nature's Delivery System to Advance Gene Therapy

Published on
Nov 5, 2021
Raymond G. Perelman Center for Cellular and Molecular Therapeutics
The Clinical Vector Core, an award-winning, state-of-the-art, multi-product GMP manufacturing facility, supports the growing field of gene therapy.

Clinical Vector Core

Photo of Clinical Vector Core Facility

The Raymond G. Perelman Center for Cellular and Molecular Therapeutics has established state-of-the-art Current Good Manufacturing Practices (cGMP) clinical vector manufacturing suites for adeno-associated virus (AAV) and lentiviral (LV) vectors.